Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends



Rating:

Share or cite this content

Citations should be made in the following way:
P. Copil (Bucharest, Romania), C. Toma (Bucharest, Romania), S. Dumitrache-Rujinski (Bucharest, Romania), T. Constantinescu (Bucharest, Romania), I. Belaconi (Bucharest, Romania), C. Ene (Bucharest, Romania), I. Ruseva (Bucharest, Romania), C. Iordache (Bucharest, Romania), E. Athir (Bucharest, Romania), R. Nemes (Bucharest, Romania). Improvement in SARS-CoV2 lung interstitial injuries with systemic corticosteroid treatment. 2534

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Experience with antifibrotics treatment in progressive interstitial lung diseases non-IPF Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005 Efficacy of pulmonary rehabilitation in patients with interstitial lung disease Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Factors affecting the compliance to antifibrotic treatment in patients with interstitial pulmonary fibrosis Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 The impact of corticosteroid on the inflammatory mediators in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury Source: Eur Respir J 2009; 33: 634-645 Year: 2009 Pneumococcal vaccination in interstitial lung disease patients receiving systemic immunosuppressive treatment Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Effect of baseline corticosteroid medication on reduction in FVC decline with nintedanib Source: International Congress 2015 – Treatment of IPF Year: 2015 Severe lung involvement in systemic scleromyxoedema: a highly unusual finding Source: Eur Respir J 2002; 19: 976-979 Year: 2002 Effectiveness of corticosteroid in diffuse alveolar hemorrhage with hematologic malignancy Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)–The LOTUSS study Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Radiation pneumonitis in an infant treated with systemic and inhaled steroids Source: Eur Respir J 2006; 28: Suppl. 50, 90s Year: 2006 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Immunosuppressive treatment is not a predictor of mortality after surgical lung biopsy for interstitial lung disease Source: International Congress 2016 – Sarcoidosis Year: 2016 Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Interstitial lung diseases and systemic disorders with lung involvement Source: ERS Skills Course 2016 Year: 2016